CAML:Central Asia Metals was the biggest faller, and after a 9% drop last week it fell another 15% this week. It looks like there is a drop across the mining sector, but none of my others dropped this much. Metal prices have dropped, but surely this is a blip, as there are shortages of supply across the board.
FXPO:Ferrexpo dropped 10% confirming the timing of my re-entry was
utterly dreadful.
JLP:Jubilee Metals fell 7%, but we should get this back as soon as
news of copper production breaks, and 7% is a remarkably small change
compared to what I usually get.
TLOU:Tlou Energy also dropped 7% but I have no idea why.
CEY:Centamin was another recent purchase and dropped 6% this week to
go 9% down already.
POLY:Polymetal also dropped by a large sum, falling 5% as the gold
price is falling.
There was only one share that gained in price this week, so
RDT:Rosslyn Data would have won Share of the Week even if it was only
up by a percent. It was actually up by 7% and some hope is re-kindled that
maybe one day I can sell at a profit.
Everything pointing downwards
Pointing upwards thanks to writing off a loss.
Here's the ISA and shares portfolio after week 46 of year 6.
The cost dropped by the £2,521 I had paid for MTFB:Motif Bio and which is almost certainly lost, as they have cancelled their AIM listing following a rejection of the 220:1 share consolidation and massive dilution of existing shareholders which was nothing short of a joke. Directors desperate to keep their salary and stuff the shareholders. Fortunately they didn't get away with it and the whole thing will almost certainly go bust. As a result I've written it off as a loss. This has wrecked my stellar Year 6 performance and brought long term performance down below my 10% target, but 9.4% for the year and 9.8% overall isn't bad, and it's a relief not to have to talk about the MTFB fiasco any more.
Weekly Change | |||
Cash | £39.08 |
+£0 | |
Portfolio cost | £68,170.47 | -£2,521.19 | |
Portfolio sell value (bid price-commission) | £55,588.26 | (-18.5%) | -£396.48 |
Potential profits | £6,+24.08 | -£150.00 | |
Yr 6 Dividends | £0 | +£0 | |
Yr 6 Profit from sales | £3,697.33 | -£2,521.19 | |
Yr 6 projected avg monthly profit | £344.41 | (9.4%) | -£250.44 |
Total Dividends | £1,343.15 | +£0 | |
Total Profit from sales | £24,123.94 | -£2,521.19 | |
Average monthly cash profit | £356.76 | (9.8%) | -£36.99 |
(Sold stocks profit + Dividends - Fees / Months) |
|||
Compound performance | 57% | -6% |
The cost dropped by the £2,521 I had paid for MTFB:Motif Bio and which is almost certainly lost, as they have cancelled their AIM listing following a rejection of the 220:1 share consolidation and massive dilution of existing shareholders which was nothing short of a joke. Directors desperate to keep their salary and stuff the shareholders. Fortunately they didn't get away with it and the whole thing will almost certainly go bust. As a result I've written it off as a loss. This has wrecked my stellar Year 6 performance and brought long term performance down below my 10% target, but 9.4% for the year and 9.8% overall isn't bad, and it's a relief not to have to talk about the MTFB fiasco any more.
Aside from the write-off, JLP:Jubilee Metals dropped £150 to dent paper
profits, and the rest of the portfolio also slipped by another £250 on top of
that. It could have been much worse as we'll see in a minute with the SIPP.
Big drop in cost from the write-off, and value just down a small amount.
Big tick up as the write-off took away £2,500 worth of loss to narrow the deficit.
Big drop in cost from the write-off, and value just down a small amount.
Big tick up as the write-off took away £2,500 worth of loss to narrow the deficit.
The SIPP looks like this after week 290 overall and week 30 of year 6.
I was depressed with everything dropping so flogged another 500 CAML;Central Asia Metals shares for 241.77p making £283.32 (30.6%) profit. I feel a bit bad that I've now sold so many, but they are drifting and there's no dividend for ages, whereas OPTI:Optibiotix is ludicrously under-valued so I had to get some more. I bought another 2,547 at 46.745p costing £1,199.55. My holding is now 163,299 giving me 13,299 I'm willing to sell and still keep 150,000 long term. My average price in the SIPP reduced to 60.78p compared to my ISA price of 60.4p. My holding is still down by £22,971 after 6 years, which is beyond frustrating, but my conviction these are going to be life changing is even stronger now, despite these losses.
Weekly Change | ||||
Cash | £207.54 | +£0.35 | ||
Portfolio cost | £73,458.48 | +£282.97 | ||
Portfolio sell value (bid price - commission) |
£56,346.81 | (-23.3%) | -£1,487.07 | |
Potential profits | £745.52 | -£844.78 | ||
Yr 6 Dividends | £874.51 | +£0 | ||
Yr 6 Interest | £0 | +£0 | ||
Yr 6 Profit from sales | £7,774.62 | +£283.32 | ||
Yr 6 projected avg monthly profit | £1,232.37 | (33.8%) | -£0.16 | |
Total Dividends | £2,941.59 | +£0 | ||
Total Interest | £0.20 | +£0 | ||
Total Profit from sales | £23,234.06 | +£283.32 | ||
Average monthly cash profit | £380.10 | (10.4%) | +£2.93 | |
(Sold stocks profit + Dividends - Fees / Months) |
||||
Compound performance | 58% | +0% |
I was depressed with everything dropping so flogged another 500 CAML;Central Asia Metals shares for 241.77p making £283.32 (30.6%) profit. I feel a bit bad that I've now sold so many, but they are drifting and there's no dividend for ages, whereas OPTI:Optibiotix is ludicrously under-valued so I had to get some more. I bought another 2,547 at 46.745p costing £1,199.55. My holding is now 163,299 giving me 13,299 I'm willing to sell and still keep 150,000 long term. My average price in the SIPP reduced to 60.78p compared to my ISA price of 60.4p. My holding is still down by £22,971 after 6 years, which is beyond frustrating, but my conviction these are going to be life changing is even stronger now, despite these losses.
Nearly everything in this portfolio got hammered, so value dropped by £1,487
and £844 of that was the huge drop in CAML:Cental Asia Metals,
compounded by selling some.
Closer to the injection line than the cost line now
Really, really bad performance over the last 6 months. Possibly the worst ever for the SIPP.
Closer to the injection line than the cost line now
Really, really bad performance over the last 6 months. Possibly the worst ever for the SIPP.
The trading account looks like this after week 256 overall and week 48 of year 5.
Most of last week's gains were lost as everything dropped. Still happy that my long term performance is much better than a building society would have been - if I can sort out the fact that the portfolio itself is down by 39% which would wipe out the whole lot if I sold up now.
No sign of recovery, which is relying on good news from DDDD:4D Pharma because the rest is going nowhere fast.
Pretty bad.
Weekly Change | |||
Cash | £259.74 | +£0 | |
Portfolio cost | £2,374.14 | +£0 | |
Portfolio sell value (bid price - commission) | £1,444.85 | (-39.1%) | -£54.19 |
Potential profits | £0.00 | +£0 | |
Year 5 Dividends | £12.18 | +£0 | |
Year 5 Profit | £651.51 | +£0 | |
Yr 5 projected avg monthly profit | £59.92 | (30.3%) | -£1.27 |
Dividends | £60.10 | +£0 | |
Profit from sales | £937.88 | +£0 | |
Average monthly cash profit | £16.89 | (8.5%) | -£0.07 |
(Sold stocks profit + Dividends - Fees / Months) |
Most of last week's gains were lost as everything dropped. Still happy that my long term performance is much better than a building society would have been - if I can sort out the fact that the portfolio itself is down by 39% which would wipe out the whole lot if I sold up now.
No sign of recovery, which is relying on good news from DDDD:4D Pharma because the rest is going nowhere fast.
Pretty bad.
So, OPTI:Optibiotix published results which most companies would have
been proud of in a Covid year, but the results was absolutely no change in
share price from the previous week. In fact, to add insult to injury
SBTX:SkinBioTherapeutics climbed much more on the day
OPTI released results than OPTI did. I'm just going to pout
and sulk for a while and see what next week brings...
No comments:
Post a Comment